{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:45:23Z","timestamp":1791193523331,"version":"4.1.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1681\/asn.2012030260","type":"journal-article","created":{"date-parts":[[2012,10,12]],"date-time":"2012-10-12T20:59:54Z","timestamp":1350075594000},"page":"1891-1899","source":"Crossref","is-referenced-by-count":69,"title":["Donor ABCB1 Variant Associates with Increased Risk for Kidney Allograft Failure"],"prefix":"10.1681","volume":"23","author":[{"given":"Jason","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Jayne","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"D\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Simmonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling E.","family":"Courtney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver J.","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cockwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.L.","family":"Gough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Opelz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Borrows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20230208","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity.","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R2-17-20230208","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0009-9236(97)90027-8","article-title":"Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine.","volume":"62","author":"Lown","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"R3-17-20230208","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1523-1755.2004.00750.x","article-title":"Alterations of CYP3A4 and P-glycoprotein activity in vivo with time in renal graft recipients.","volume":"66","author":"Lemahieu","year":"2004","journal-title":"Kidney Int"},{"key":"R4-17-20230208","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2165\/00003088-200342150-00003","article-title":"Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.","volume":"42","author":"Wang","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"R5-17-20230208","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00003088-200140030-00002","article-title":"The gut as a barrier to drug absorption: Combined role of cytochrome P450 3A and P-glycoprotein.","volume":"40","author":"Zhang","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"R6-17-20230208","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","article-title":"Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.","volume":"66","author":"Liu","year":"1991","journal-title":"Cell"},{"key":"R8-17-20230208","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1097\/00007890-200212150-00002","article-title":"Tacrolimus pharmacogenetics: Polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement.","volume":"74","author":"Macphee","year":"2002","journal-title":"Transplantation"},{"key":"R10-17-20230208","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1681\/ASN.2008080819","article-title":"ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcome.","volume":"20","author":"Cattaneo","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R11-17-20230208","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/TP.0b013e318187c4d1","article-title":"Haplotypic structure of ABCB1\/MDR1 gene modifies the risk of the acute allograft rejection in renal transplant recipients.","volume":"86","author":"Bandur","year":"2008","journal-title":"Transplantation"},{"key":"R12-17-20230208","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1432-2277.2008.00679.x","article-title":"Association of four DNA polymorphisms with acute rejection after kidney transplantation.","volume":"21","author":"Griny\u00f3","year":"2008","journal-title":"Transpl Int"},{"key":"R13-17-20230208","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.tpj.6500488","article-title":"CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine.","volume":"8","author":"Kreutz","year":"2008","journal-title":"Pharmacogenomics J"},{"key":"R14-17-20230208","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/MNH.0b013e32830f4579","article-title":"Genetic prediction of renal transplant outcome.","volume":"17","author":"Goldfarb-Rumyantzev","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R15-17-20230208","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1592\/phco.2005.25.6.779","article-title":"Calcineurin inhibitor-induced nephrotoxicity and renal expression of P-glycoprotein.","volume":"25","author":"Joy","year":"2005","journal-title":"Pharmacotherapy"},{"key":"R16-17-20230208","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/ndt\/gfm133","article-title":"Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity.","volume":"22","author":"Joy","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R17-17-20230208","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1681\/ASN.2004100882","article-title":"ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation.","volume":"16","author":"Hauser","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R18-17-20230208","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/clpt.2010.62","article-title":"Donor P-gp polymorphisms strongly influence renal function and graft loss in a cohort of renal transplant recipients on cyclosporine therapy in a long-term follow-up.","volume":"88","author":"Woillard","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"R19-17-20230208","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.1135308","article-title":"A \u201csilent\u201d polymorphism in the MDR1 gene changes substrate specificity.","volume":"315","author":"Kimchi-Sarfaty","year":"2007","journal-title":"Science"},{"key":"R20-17-20230208","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nature09298","article-title":"Integrating common and rare genetic variation in diverse human populations.","volume":"467","author":"Altshuler","year":"2010","journal-title":"Nature"},{"key":"R21-17-20230208","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1681\/ASN.2009020192","article-title":"Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts.","volume":"20","author":"Naesens","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R22-17-20230208","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1600-6143.2005.01050.x","article-title":"Predicting subsequent decline in kidney allograft function from early surveillance biopsies.","volume":"5","author":"Cosio","year":"2005","journal-title":"Am J Transplant"},{"key":"R23-17-20230208","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00007890-200102270-00006","article-title":"Effect of histological damage on long-term kidney transplant outcome.","volume":"71","author":"Nankivell","year":"2001","journal-title":"Transplantation"},{"key":"R24-17-20230208","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.TP.0000128636.70499.6E","article-title":"Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology.","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"R25-17-20230208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1389200043489108","article-title":"The role of MDR1 genetic polymorphisms in interindividual variability in P-glycoprotein expression and function.","volume":"5","author":"Woodahl","year":"2004","journal-title":"Curr Drug Metab"},{"key":"R26-17-20230208","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jb\/mvm242","article-title":"Involvement of MDR1 function in proliferation of tumour cells.","volume":"143","author":"Katoh","year":"2008","journal-title":"J Biochem"},{"key":"R27-17-20230208","doi-asserted-by":"crossref","first-page":"11169","DOI":"10.1021\/bi9627830","article-title":"Human MDR 1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts.","volume":"36","author":"Robinson","year":"1997","journal-title":"Biochemistry"},{"key":"R28-17-20230208","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/ejvs.2001.1378","article-title":"Lipid metabolism and molecular changes in normal and atherosclerotic vessels.","volume":"22","author":"Petruzzo","year":"2001","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R29-17-20230208","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/sj.ki.5002522","article-title":"P-glycoprotein-deficient mice have proximal tubule dysfunction but are protected against ischemic renal injury.","volume":"72","author":"Huls","year":"2007","journal-title":"Kidney Int"},{"key":"R30-17-20230208","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3727\/096368910X504478","article-title":"Deficiency of either P-glycoprotein or breast cancer resistance protein protect against acute kidney injury.","volume":"19","author":"Huls","year":"2010","journal-title":"Cell Transplant"},{"key":"R31-17-20230208","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1172\/JCI20921","article-title":"The renal papilla is a niche for adult kidney stem cells.","volume":"114","author":"Oliver","year":"2004","journal-title":"J Clin Invest"},{"key":"R32-17-20230208","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5115\/acb.2011.44.3.186","article-title":"Intra-renal slow cell-cycle cells contribute to the restoration of kidney tubules injured by ischemia\/reperfusion.","volume":"44","author":"Kim","year":"2011","journal-title":"Anat Cell Biol"},{"key":"R33-17-20230208","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00008571-200311000-00002","article-title":"Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors.","volume":"13","author":"Hebert","year":"2003","journal-title":"Pharmacogenetics"},{"key":"R34-17-20230208","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.clpt.2004.01.009","article-title":"CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation.","volume":"75","author":"Anglicheau","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"R35-17-20230208","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/FPC.0b013e3282f7046f","article-title":"Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients.","volume":"18","author":"Crettol","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"R36-17-20230208","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1399-0012.2008.00867.x","article-title":"A search for cyclophilin-A gene variants in cyclosporine A-treated renal transplanted patients.","volume":"22","author":"Moscoso-Solorzano","year":"2008","journal-title":"Clin Transplant"},{"key":"R37-17-20230208","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/j.gastro.2005.12.008","article-title":"The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease.","volume":"130","author":"Dring","year":"2006","journal-title":"Gastroenterology"},{"key":"R38-17-20230208","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/ibd.20252","article-title":"Role of the PXR gene locus in inflammatory bowel diseases.","volume":"13","author":"Mart\u00ednez","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R39-17-20230208","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1126\/science.1069424","article-title":"The structure of haplotype blocks in the human genome.","volume":"296","author":"Gabriel","year":"2002","journal-title":"Science"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201211000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:22:10Z","timestamp":1786130530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201211000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2012030260","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}